RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
Health and Human Services, Department of · OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
- Response deadline
- Jul 29, 2026, 8:00 PM EDT
- Posted
- Jul 1, 2026
- Solicitation
- 75A50126R00002
- Set-aside
- No Set aside used
- Place of performance
- Washington, DC, USA
- Contracting office
- BARDA - ASPR / DAAPPO / BARDA DCMA · WASHINGTON · DC
- Source
- SAM.gov · updated Jul 2, 2026
Description
BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$404,976
Middle of the pack for similar past awards
Most similar awards fall between $45,429 and $2.81M
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1ADVANCED TECHNOLOGY INTERNATIONAL5 awards$2.27B
- 2AMGEN USA INC2 awards$714.70M
- 3SIGA TECHNOLOGIES, INC.1 award$624.44M
- 4ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.5 awards$383.82M
- 5ALLUCENT GOVERNMENT SERVICES (US) LLC5 awards$375.68M
- 6TECHNICAL RESOURCES INTERNATIONAL, INC.9 awards$363.64M
- 7MAPP BIOPHARMACEUTICAL, INC.4 awards$315.08M
- 8ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)2 awards$305.87M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID 475c5939d56548529d8a1d73665697e7.